Amsterdam, June 2, 2014 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today its publishing agreement with The CBS-KNAW Fungal Biodiversity Centre, an institute of the Royal Netherlands Academy of Arts and Sciences. Per June 2014 it will publish and host the organization's official journal: Studies in Mycology (SiM), which will be made available open access on ScienceDirect.
The CBS-KNAW Fungal Biodiversity Centre hosts a world-renowned collection of living filamentous fungi, yeasts and bacteria numbering more than 80,000. In diversity of species it is unrivalled as a reference centre for mycological research. Its journal Studies in Mycology publishes systematic monographs of filamentous fungi and yeasts, with special issues on all fields of mycology, including biotechnology, ecology, molecular biology, plant and human pathology. Papers follow the current molecular and polyphasic taxonomic approaches and are richly illustrated by high quality colour images, and interactive links to MycoBank, GenBank and culture collections such as the CBS.
Studies in Mycology was first launched in 1972. In 2002 SiM became the first OA journal listed in Web of Knowledge in the field of mycology and since 2007 it has been the leading journal in the field based on impact factor.
According to the Editor-in-Chief, Prof. Robert A. Samson of the CBS-KNAW Fungal Biodiversity Centre, the main reason for selecting Elsevier to publish the journal is its ambition to not only publish cutting-edge research, but also the possibility to directly link to other published datasets in different fields of biology.
"Elsevier will help us achieve our future goals for the journal. Plans include, among others: enabling research papers to be interactively linked to live databases and multimedia hosted elsewhere and which too are constantly evolving; thus helping scientists to ask more in-depth questions than previously possible," said Samson.
"It is with great excitement that we announce this collaboration with the CBS-KNAW Fungal Biodiversity Centre in the Netherlands. We are looking forward to contributing to the further development of Studies in Mycology by applying the global reach and innovative functionality of our journal platforms," says Bernard Aleva, Sr. Vice President of Innovation and Publishing Development at Elsevier.
About Elsevier's Production & Hosting program
Production & Hosting by Elsevier provides a publishing solution for societies, universities, academies of science, government agencies, and other academic journal owners who are looking to improve the quality of their publication. An experienced team works closely with the client at every step of the way to follow their publishing strategy. Elsevier provides the tools, resources and expertise (such as access to the Elsevier Editorial System, hosting on ScienceDirect, and hosting a journal homepage on http://www.
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 100 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. In addition, Elsevier hosts over 90 third-party owned open access journals on ScienceDirect. For more information about Elsevier's open access program, visit http://www.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey -- and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+31 20 4853817